Letter/Comment

Dec 21, 2020
AHA letter requesting the Biden Administration exercise enforcement discretion with respect to compliance with the Centers for Medicare…
Jan 31, 2023
January 31, 2023 April Tabor Secretary Federal Trade Commission 600 Pennsylvania Avenue NW Suite CC-5610 (Annex C) Washington, DC 20580 Re: Notice of Proposed Rulemaking, Federal Trade Commission; Non-Compete Clause Rule; 88 Fed. Reg. 3482 (RIN: 3084-AB74) (January 19, 2023) Dear Ms. Tabor:
Jan 30, 2023
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.
Jan 30, 2023
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform
Jan 30, 2023
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
Jan 27, 2023
January 27, 2023 Emeka Egwim, PharmD, RPh LCDR U.S. Public Health Service Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, 08W05A Rockville, MD 20857 RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket…